Aurora Cannabis Inc - Asset Resilience Ratio

Latest as of June 2026: 4.95%

Aurora Cannabis Inc (ACB) has an Asset Resilience Ratio of 4.95% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Aurora Cannabis Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$30.74 Million
Cash + Short-term Investments

Total Assets

$621.15 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2026)

This chart shows how Aurora Cannabis Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Aurora Cannabis Inc balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Aurora Cannabis Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Aurora Cannabis Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $30.74 Million 4.95%
Total Liquid Assets $30.74 Million 4.95%

Asset Resilience Insights

  • Limited Liquidity: Aurora Cannabis Inc maintains only 4.95% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Aurora Cannabis Inc Industry Peers by Asset Resilience Ratio

Compare Aurora Cannabis Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
Drug Manufacturers - Specialty & Generic 2.79%
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 2.51%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Harbin Pharmaceutical Group Co Ltd
SHG:600664
Drug Manufacturers - Specialty & Generic 0.97%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%

Annual Asset Resilience Ratio for Aurora Cannabis Inc (2009–2026)

The table below shows the annual Asset Resilience Ratio data for Aurora Cannabis Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 8.69% $52.35 Million $602.64 Million +8.62pp
2025-03-31 0.06% $550.82K $847.77 Million -0.42pp
2024-03-31 0.48% $4.04 Million $840.14 Million +0.34pp
2022-03-31 0.14% $1.33 Million $926.38 Million +0.01pp
2021-03-31 0.14% $3.75 Million $2.72 Billion -0.10pp
2020-03-31 0.24% $7.04 Million $2.92 Billion -2.31pp
2019-03-31 2.55% $143.80 Million $5.64 Billion -0.59pp
2018-03-31 3.14% $59.59 Million $1.90 Billion -1.49pp
2017-03-31 4.63% $14.98 Million $323.82 Million +4.24pp
2016-03-31 0.39% $71.00K $18.32 Million +0.38pp
2015-03-31 0.01% $1.50K $13.53 Million -97.50pp
2012-03-31 97.51% $1.13 Million $1.16 Million +0.25pp
2011-03-31 97.26% $1.35 Million $1.39 Million +8.79pp
2010-03-31 88.46% $1.53 Million $1.73 Million -8.62pp
2009-03-31 97.09% $1.58 Million $1.62 Million --
pp = percentage points

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic
Market Cap
$270.33 Million
Market Cap Rank
#16022 Global
#3800 in USA
Share Price
$4.27
Change (1 day)
+5.96%
52-Week Range
$2.58 - $6.23
All Time High
$1416.62
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis… Read more